A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases - Takeaways - MDSpire

A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases

  • By

  • Smruti Mahapatra

  • Laurel Seltzer

  • Neydin Osorio

  • Michelle Miller

  • Andrew Janssen

  • Raj Mitra

  • Joseph Keen

  • Clayton Smith

  • Marcus Ware

  • June 7, 2025

  • 0 min

Share

  • 1

    Metastatic brain tumors are prevalent in cancer patients, with treatment options including surgery, radiation therapy, and chemotherapy.

  • 2

    Cs-131 stereotactic brachytherapy has advantages over I-125, including a shorter half-life and lower rates of radiation necrosis.

  • 3

    Minimally invasive keyhole craniotomy reduces trauma and recovery time, providing access to difficult tumor locations.

  • 4

    This study aims to evaluate the combined efficacy of MIKC and Cs-131 SBT for local control and functional outcomes in brain oligometastases.

  • 5

    Twenty-one adults with newly diagnosed brain metastases participated in the study, with outcomes assessed over two years using various criteria.

Original Source(s)

A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases

  • by Smruti Mahapatra, Laurel Seltzer, Neydin Osorio, Michelle Miller, Andrew Janssen, Raj Mitra, Joseph Keen, Clayton Smith, Marcus Ware

  • June 7, 2025

Related Content

Beyond Treatment Volume: When Pelvic Radiotherapy May Still Matter in High-Risk Localised Prostate Cancer

Ablative stereotactic MR-guided radiotherapy for >10 cm solid pseudopapillary tumor of the pancreas with liver oligometastases: a case report and literature review

Peripheral blood monocytes could be associated with brain metastasis and affect patient prognosis in breast cancer: a retrospective study